Atlas Trials

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Clinical trial NCT04333576 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04333576
Sponsor
AbbVie
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Endometriosis
Start date
2020-08-10
Primary completion
2027-07-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.